研究：美国家卫生研究院今年逾380项临床试验被迫中止

Core Insights - The Trump administration's significant reduction in federal research funding has led to the cancellation of over 380 clinical trials funded by the National Institutes of Health (NIH) from February to August this year, affecting more than 74,000 participants [1][2] - The halted clinical trials primarily focused on infectious disease research, prevention, behavioral interventions, as well as studies related to cancer, cardiovascular diseases, and mental health [1] - The abrupt funding cuts raise concerns about resource wastage, declining data quality, and the inability of researchers to fulfill their ethical responsibilities to participants [1] Research Impact - The study published in the Journal of the American Medical Association highlights that the interruption of these clinical trials lacks scientific justification and violates fundamental ethical principles of human subject research [1] - The implications of these funding cuts extend beyond the immediate trials, potentially causing long-term damage to the entire public health research ecosystem in the United States [2] - Public health experts emphasize that basic medical research relies on long-term planning and sustained investment, indicating that the effects of reduced research funding could be profound and lasting [2]